Abstract
The Budd-Chiari syndrome (BCS) used to be a very rare disorder and lacked a means of relieving. However, various shuntings and radical procedures have emerged in the last three decades with quite encouraging outcomes. Recent minimally invasive therapies, such as stenting of the inferior vena cava (IVC), are simple and easy to handle. However, it has been realized that the IVC stent may compromise the hepatic veins and cause catastrophic consequences, thus the indication for IVC stenting should be reevaluated and especially not to be overused. Instead, it should be applied by percutaneous transangiography (PTA) only, which may be repeated when necessary. The BCS in China predominantly belongs to the IVC type rather than the intrahepatic type in Western; the outcome from its conventional therapy, at least for the moment, is better than that of liver transplantation. It is thus suggested that, before liver transplantation is decided, the conventional means for managing BCS be considered. The final suggestion is to restrict the indication both for stenting of the IVC and liver transplantation. In this paper, ten examples are given with figures.
Similar content being viewed by others
References
Wang Z G, Zhu Y, Wang S H, Pu L P, Du Y H, Zhang H, Yuan C, Chen Z, Wei M L, Pu L Q, et al. Recognition and management of Budd-Chiari syndrome: Report of one hundred cases. J Vasc Surg. 1989, 10(2): 149–156
Wang Z G, Jones S. Budd-Chiari syndrome. Curr Probl Surg, 1996, 33: 81–140
Wang Z G, Zhang F J, Li X Q, Meng Q Y. Management of Budd-Chiari syndrome: what is the best approach? J Gastroenterol Hepatol, 2004, 19: S212–S218
Wang Z G, Zhang F J, Yi M Q, Qiang L X. Evolution of management for Budd-Chiari syndrome: A team view from 2564 patients. ANZ J Surg, 2005, 75(1–2): 55–63
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Z. To restrict indication for stenting of the inferior vena cava and liver transplantation in patients with Budd-Chiari syndrome. Front. Med. China 1, 130–135 (2007). https://doi.org/10.1007/s11684-007-0025-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-007-0025-3